Effect of apolactoferrin on experimental pneumococcal otitis media.

نویسندگان

  • Patricia A Schachern
  • Vladimir Tsuprun
  • Sebahatin Cureoglu
  • Patricia A Ferrieri
  • David E Briles
  • Michael M Paparella
  • Steven K Juhn
چکیده

OBJECTIVE To find the effect of apolactoferrin administration on the middle and inner ears after experimentally induced pneumococcal otitis media. DESIGN Histopathologic and morphometric analysis of the middle and inner ears. SETTING University of Minnesota, Minneapolis. SUBJECTS Ten chinchillas. INTERVENTIONS The middle ear cavities of chinchillas were inoculated bilaterally with type 2 wild-type Streptococcus pneumoniae. Twenty-four hours later, the ears of 5 of the animals were injected with phosphate-buffered saline (PBS) and the other 5 with human apolactoferrin. The animals were killed 24 hours after the last injection. Bacterial counts were made of the middle ear effusions, and the cochleae were processed for histologic analysis. The thickness of the round window membranes and bacterial and inflammatory cell infiltration of the round window membranes, and scala tympani and damage of the hair cells and stria vascularis were compared for these 2 groups of animals. MAIN OUTCOME MEASURES Comparison of inflammatory and bacterial cells in the middle and inner ears, and damage to inner ear structures. RESULTS Bacterial plate counts of middle ear effusions (P  = .005) and the number of inflammatory cells in the round window membrane (P  = .047) were significantly lower in the apolactoferrin group compared with the group treated with PBS. CONCLUSION Further investigation of apolactoferrin as a nonantibiotic approach for the treatment of otitis media and its complications is needed to confirm its safety and efficacy.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Otitis media with effusion (serous otitis media) in children: Management Authors

Authors Jerome O Klein, MD Stephen Pelton, MD Section Editors Sheldon L Kaplan, MD Ellen M Friedman, MD Deputy Editor Mary M Torchia, MD Disclosures: Jerome O Klein, MD Consultant/Advisory Boards: GlaxoSmithKline [Vaccines (Pneumococcal)]; Cubist [Antibiotic for Clostridium difficile (Fidaxomicin)]. Stephen Pelton, MD Grant/Research/Clinical Trial Support: Pfizer [pneumococcal disease surveilla...

متن کامل

A live-attenuated pneumococcal vaccine elicits CD4+ T-cell dependent class switching and provides serotype independent protection against acute otitis media

Acute otitis media (AOM) caused by Streptococcus pneumoniae remains one of the most common infectious diseases worldwide despite widespread vaccination. A major limitation of the currently licensed pneumococcal vaccines is the lack of efficacy against mucosal disease manifestations such as AOM, acute bacterial sinusitis and pneumonia. We sought to generate a novel class of live vaccines that (1...

متن کامل

Penicillin treatment accelerates middle ear inflammation in experimental pneumococcal otitis media.

Most Streptococcus pneumoniae strains are killed by very low concentrations of penicillin and other beta-lactam antibiotics, yet middle ear inflammation and effusion persist for days to weeks after treatment in most cases of pneumococcal otitis media. To study the effect of beta-lactam antibiotic treatment on pneumococci and the middle ear inflammatory response during pneumococcal otitis media,...

متن کامل

Serum antibodies to pneumococcal neuraminidase NanA in relation to pneumococcal carriage and acute otitis media.

Pneumococcal neuraminidase, NanA, is a pneumococcal vaccine candidate. Prior culture-confirmed pneumococcal contacts were shown to induce serum anti-NanA antibodies during the first 2 years of life. The antibody concentrations at neither 12 nor 18 months were significantly associated with the risk of subsequent pneumococcal carriage or acute otitis media.

متن کامل

Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype--implications for vaccine effect.

BACKGROUND Clinical symptoms and signs in acute otitis media (AOM) may differ depending on the various pneumococcal serotypes causing the disease. Alteration in clinical presentation of AOM could be expected after wide-scale pneumococcal vaccinations if there were considerable differences between vaccine serotypes and nonvaccine serotypes. METHODS In this study, data from 831 children in the ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Archives of otolaryngology--head & neck surgery

دوره 136 11  شماره 

صفحات  -

تاریخ انتشار 2010